LIFEVANTAGE CORP Income Taxes Receivable, Current
LIFEVANTAGE CORP (LFVN) had Income Taxes Receivable, Current of $1.39 million as of 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Notes
us-gaap:IncomeTaxesReceivable · last filed 2026-08-27
- 2026-06-30: Income Taxes Receivable, Current $1.39M.
- 2026-03-31: Income Taxes Receivable, Current $2.20M.
- 2025-12-31: Income Taxes Receivable, Current $2.73M.
- 2025-09-30: Income Taxes Receivable, Current $5.30M.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2026-06-30 | $1.39M 10-K · filed 2026-08-27 |
| 2026-03-31 | $2.20M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $2.73M 10-Q · filed 2026-02-04 |
| 2025-09-30 | $5.30M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $635.00K 10-K · filed 2026-08-27 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-06 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-05 |
| 2024-09-30 | $886.00K 10-Q · filed 2024-10-29 |
| 2024-06-30 | $313.00K 10-K · filed 2025-09-04 |
| 2024-03-31 | $360.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $234.00K 10-Q · filed 2024-01-30 |
| 2023-09-30 | $149.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $241.00K 10-K · filed 2024-08-28 |
| 2023-03-31 | $662.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $891.00K 10-Q · filed 2023-02-02 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-02 |
| 2022-06-30 | $1.75M 10-K · filed 2023-08-28 |
| 2022-03-31 | $805.00K 10-Q · filed 2022-05-03 |
| 2021-12-31 | $897.00K 10-Q · filed 2022-02-01 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.04M 10-K · filed 2022-08-23 |
| 2021-03-31 | $764.00K 10-Q · filed 2021-04-29 |
| 2020-12-31 | $536.00K 10-Q · filed 2021-02-02 |
| 2020-09-30 | $98.00K 10-Q · filed 2020-11-03 |
| 2020-06-30 | $0.00 10-K · filed 2021-08-19 |
| 2020-03-31 | $2.38M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $1.01M 10-Q · filed 2020-01-28 |
| 2019-09-30 | $1.85M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $1.24M 10-K · filed 2020-08-18 |
| 2019-03-31 | $2.72M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $2.87M 10-Q · filed 2019-02-04 |
| 2018-09-30 | $1.36M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $451.00K 10-K · filed 2019-08-14 |
| 2018-03-31 | $280.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $86.00K 10-Q · filed 2018-02-07 |
| 2017-09-30 | $472.00K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $913.00K 10-K · filed 2018-08-15 |
| 2017-03-31 | $2.63M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $903.00K 10-Q · filed 2017-02-08 |
| 2016-09-30 | $133.00K 10-Q · filed 2016-12-12 |
| 2016-06-30 | $0.00 10-K · filed 2017-09-07 |
| 2016-03-31 | $2.23M 10-Q/A · filed 2016-07-19 |
| 2015-12-31 | $2.21M 10-Q · filed 2016-02-09 |
| 2015-09-30 | $2.81M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $2.18M 10-K · filed 2016-12-12 |
| 2015-03-31 | $3.49M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $2.32M 10-Q · filed 2015-02-04 |
| 2014-09-30 | $2.81M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $4.68M 10-K · filed 2015-09-01 |
| 2014-03-31 | $1.51M 10-Q · filed 2014-05-06 |
| 2013-12-31 | $651.00K 10-Q · filed 2014-02-06 |
| 2013-09-30 | $298.00K 10-Q · filed 2013-11-07 |
| 2013-06-30 | $2.15M 10-K · filed 2014-09-10 |
| 2012-06-30 | $0.00 10-K · filed 2013-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |